Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Nektar continues to make progress with rezpegaldesleukin, with results from phase 2 atopic dermatitis study expected in H1'25 ...

Background: Atopic dermatitis (AD) may be exacerbated by occlusion from items such as occlusive gloves or textiles, especially if the occlusion is removed suddenly, creating a steep humidity gradient.

The researchers utilized a Fra-2 transgenic mouse model that encompasses many of the features of systemic sclerosis in humans, including spontaneous systemic inflammation and fibrosis in the lungs, ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Jefferies raised the firm’s price target on Corvus Pharmaceuticals (CRVS) to $13 from $8 and keeps a Buy rating on the shares ahead of ...

The company has shown significant progress with its lead asset, soquelitinib, particularly in treating atopic dermatitis (AtD). The upcoming interim Phase 1 data, expected in December, has generated ...

Types of dermatitis Dermatitis encompasses various types, each with unique characteristics. Atopic Dermatitis, commonly known as eczema, manifests as chronic, itchy, and inflamed skin persisting from ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...

The company is also evaluating soquelitinib to treat soquelitinib in patients with moderate to severe atopic dermatitis in a ...

as well as OPZELURA cream for treatment of atopic dermatitis. Receive News & Ratings for Incyte Daily - Enter your email ...

Additionally, you want to aim for shorter showers. “For patients with atopic dermatitis and/or very dry skin, I recommend ...